Vincera SPAC Presentation Deck
September 2020, 35 slides
  1. Vincera
  2. SPAC Presentation Decks
overview | Vincera
important notices | Vincera
forward looking statements a | Vincera
we aspire to conquer cancer by addressing the unmet medical | Vincera
highlights a apa | Vincera
| Vincera
management team experience proven track record | Vincera
pipeline | Vincera
program phase oral discovery | Vincera
summary of portfolio clinical discovery | Vincera
a novel target for oncology role of role of inhibitors currently in phase difficult to target | Vincera
is a clinically validated target i | Vincera
is the most selective inhibitor in the clinic i | Vincera
highly selective and potent inhibitor a | Vincera
inhibits the transcription of and | Vincera
clinical trial design status | Vincera
pharmacodynamic activity in patient samples | Vincera
manageable safety profile | Vincera
early signs of efficacy in phase with | Vincera
complete metabolic response observed in patient with treatment refractory double hit | Vincera
poor prognosis in double hit lymphoma | Vincera
potential indications | Vincera
clinical development plan | Vincera
summary portfolio | Vincera
platform | Vincera
proprietary platforms shaping the future | Vincera
small molecule drug conjugate | Vincera
key features of cancer cell surface targeting | Vincera
dual targeting rationale | Vincera
platform | Vincera
next generation technology solutions | Vincera
key features of an in months | Vincera
key features of a | Vincera
expected upcoming milestones | Vincera
summary | Vincera
See More
Vincera
SPAC Presentation Decks
Explore Topics
Tumor
Inhibitor
Solid tumor
Drug development
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights